SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-18-017995
Filing Date
2018-03-29
Accepted
2018-03-29 16:52:55
Documents
68
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tv488786_10k.htm 10-K 971112
2 EXHIBIT 10.47 tv488786_ex10-47.htm EX-10.47 36476
3 EXHIBIT 10.48 tv488786_ex10-48.htm EX-10.48 108421
4 EXHIBIT 23.1 tv488786_ex23-1.htm EX-23.1 2740
5 EXHIBIT 31.1 tv488786_ex31-1.htm EX-31.1 10460
6 EXHIBIT 32.1 tv488786_ex32-1.htm EX-32.1 5265
  Complete submission text file 0001144204-18-017995.txt   6342758

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rgrx-20171231.xml EX-101.INS 1486917
8 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20171231.xsd EX-101.SCH 55400
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20171231_cal.xml EX-101.CAL 44594
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20171231_def.xml EX-101.DEF 312376
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20171231_lab.xml EX-101.LAB 376242
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20171231_pre.xml EX-101.PRE 367186
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15070 | Film No.: 18723611
SIC: 2834 Pharmaceutical Preparations